MedTrace Logo

Microbiota Profiling in IBS

NCT03720314 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 121

Last updated 2019-02-21

No results posted yet for this study

Summary

This study investigates differences in microbiota profiles and metabolite levels between mild and severe IBS patients, compared to matched healthy controls. Two fecal samples, with one month in between, will be analyzed. Secondary parameters such as dietary intake, quality of life and stool pattern will be assessed.

Conditions

  • Irritable Bowel Syndrome
  • Microbial Colonization
  • Dietary Habits

Interventions

OTHER

NA observational study

observational study

Sponsors & Collaborators

  • Netherlands: Ministry of Health, Welfare and Sports

    collaborator OTHER_GOV

  • Ingredia S.A.

    collaborator INDUSTRY

  • Nexira

    collaborator INDUSTRY

  • Naturex

    collaborator OTHER

  • Bioiberica

    collaborator INDUSTRY

  • Wecare

    collaborator OTHER

  • Roquette Freres

    collaborator INDUSTRY

  • Darling

    collaborator UNKNOWN

  • Winclove Bio Industries BV

    collaborator INDUSTRY

  • Wageningen University

    lead OTHER

Principal Investigators

  • Ben Witteman, Prof MD PhD · Wageningen University & Research

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-09-06
Primary Completion
2018-12-15
Completion
2018-12-15

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03720314 on ClinicalTrials.gov